Antimicrobial Resistant Gram-Negative Infections: Conversations with the Microbiology Lab

Course Overview

Clinical pharmacists are often challenged with antibiotic selection for patients infected with multi-drug resistant organisms. There have been numerous new and novel antibiotics that have received FDA approval over the last decade. Many of these agents are not included on routine antibiotic susceptibility testing panels in hospital-based microbiology labs. Collaboration between the clinical microbiology lab and pharmacy is integral to developing processes and pathways for performing susceptibility testing of novel antibiotics.

Who Should Attend

This course has been designed for:

• Pharmacists
• Pharmacy Residents
• Physicians
• Physician Assistants
• Clinicians
• Medical Residents
• Nurses and Nurse Practitioners

Learning Objectives

Upon completion of this activity, participants will be able to:

• Interpret microbiology susceptibility test results for novel antimicrobial agents relevant to the management, and monitoring of patients with multi-drug resistant infections
• Describe the added spectrum of activity of novel gram-negative antibiotics